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The administration of 3,4-dihydroxyphenylalanine 
(L-Dopa) has been shown to result in the facilitation of 
performance while the administration of 5-hydroxytrypto­
phan (5-HTP) results in an impairment of performance and 
reported enhancement of aCQuisition. The purpose of the 
present study is to compare the effects of 5-HTP and 1­
Dopa on the acquisition of a single behavioral task. 
Each animal received a total of twenty daily trials 
in a shuttle box one hour after injection. All mice 
learned to avoid footshock both during each trial and the 
inter-trial interval. The results indicate that 5-HTP and 
L-Dopa do not facilitate the acquisition of a conditioned 
avoidance task. A significant number of inter-trial cross­
overs was obtained for the L-Dopa group for the 13 days of 
training and the 5-HTP group for the first 2 days. 
It was concluded that possible peripheral effects 
of L-Dopa interfered with acquisition. It was suggested 
that the effects of 5-HTP upon the visual system might 
have served to inhibit acquisition of a visual task. In 
view of the subject x treatment interaction, it would 
appear that the metabolites of 5-HTP and L-Dopa produced 
effects which varied within sUbjects as a function of the 
daily administration of precursors. 
The further analysis of effects of 5-HTP and L­
Dopa on acquisition should includ~ correlation~ ~etween 
variations in regional concentrat~ons and specl.fl.c be­
haviors. 
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CHAPTER I 
INTRODUCTION 
Through the use of behavioral and biochemical method­
ologies, the role of the monoamines in the study of brain 
function as well as the chemotherapy of behavior disorders 
has been the focus of much interest (Himwich & Schade, 1965). 
Currently, the study of the effects of monoaminergic neuro­
transmitters provides a basis for much of the work under­
taken in the area of psychopharmacology. An analysis of the 
behavioral effects of increased brain levels of 5-hydroxy­
tryptamine (5-HT) and dopamine (DA) often serve as a pre­
liminary tool for the evaluation of these drug effects. How­
ever, investigations of the effects of various levels of 
brain 5-HT and DA upon animal behavior have resulted in a 
wide variety of conflicting reports. 
Brain levels of biogenic amines such as 5-HT, a pro­
posed central nervous system (eNS) neurotransmitter (Eiduson, 
Geller. Yuwiler & Eiduson, 1964; Yalzelli, 1973), and DA, 
which is necessary for the production of norepinephrine (NE), 
have been shown to be elevated by the administration of 
their respective precursors, 5-hydroxytryptophan (5-HTP) and 
3,4-dihydroxyphenylalanine (L-Dopa). While the administration 
of 5-HTP results in increased brain levels of 5-HT (Green & 
Sawyer, 1964), it is also reported that brain levels of NE 
ir1crease (Ol{ada, Saito. Fujieda & Yamashita, 1972). As a re­
sult of precursor loadIng for DA there is an increase of DA 
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and NE (Kellogg & Lundborg, 1972) as well as a concomitant 
decrease of 5-HT in mice (Everett & Borcherding, 1970). 
Utilizing the technique of precursor loading, much re­
search with animals has been done with respect to performance 
on a given task. Aprison and Ferster (1961a, 1961b) have dem­
onstrated a disruption of pecking behavior in pigeons result­
ing from the administration of 5-HTP (25, 50 and 75 mg/kg). 
A concomitant temporal relationship between decreased perform­
ance and 5-HT concentrations in the diencephalic and telen­
cephalic regions of the brain of the pigeon as a result of 
the administration of 50 mg/kg of 5-HTP was also reported 
(Aprison, Wolf, Poulos &·Folkerth, 1962). Other studies have 
demonstrated that increased brain levels of 5-HT can impair 
the ability of cats to perform in a conditioned avoidance 
situation in order to avoid foot shock (McGeer, P. L., Wada, 
& McGeer, E. G., 196Jb) and results in a deleterious effect 
on performance in a conditioned avoidance situation when a 
shuttle response to auditory stimuli is required (Wada, Wrinch, 
Hill & McGeer, 1963). 
On the other hand, reports of the effects of decreased 
levels of brain 5-HT have produced a variety of effects which 
appear to vary with the particular methodology employed. Some 
of the behavioral effects of para-chlorophenylalanine (PCPA), 
a reported specific depletor of brain 5-HT (Koe & Weissman, 
1966), are an enhancement of acquisition of the active avoid­
ance response at low shock intensities but not at higher sheck 
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intensities (Tenen, 1967); facilitation of acquisition of 
brightness discrimination in water deprived and satiated rats 
(Stevens, 1970), an enhancement of performance in conditioned 
avoidance situations for single injections and retardation by 
chronic treatment (Schlesinger & Schreiber. 1968); retarda­
tion of simultaneous brightness and simultaneous pattern dis­
crimination (Fifer1 , Yuwiler & Geller). and no difference up­
on food rewarded maze performance (McFarlain & Bloom. 1972). 
Recent studies would indicate that the behavioral 
effects of PCPA may be the result of nonspecific effects 
upon brain biogenic amines. PCPA (300 mg/kg) has been shown 
to lower the NE content of rat brain by 81 percent of that of 
controls 2 hours after injection and 84 percent of controls 
after 24 hours (Peters, Filczewski & Mazurkiewicz-Kwilecki. 
1972). The nonspecificity of PCPA in relation to the deple­
tion of 5-HT may provide a possible explanation for conflict­
ing behavioral reports. Stark and Fuller (1972) suggest that 
the effect of PCPA is to lower the brain levels of the cat­
echolamines and 5-HT as a result of a PCPA metabolite which 
inhibits tyrosine hydroxylase and tryptophan hydroxylase. 
The effects of increased or decreased catecholamine 
levels within the brain tend to reflect a more consistent 
effect upon the performance of the tasks investigated. It 
has been demonstrated that a facilitation of performance 
lUnpublished study entitled lff{etardation of visua~ Dis­
crimination l}earning in the Rat by Para-Chlorophenylalan~ne, It 
19650 Now at DraJ\.e University, Des Moines, Iowa 50311. 
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upon a shuttle task in conjunction with a marked decrease in 
the mean latency of the avoidance response can occur as a re­
sult of the administration of 20-50 mg/kg of L-Dopa (Wada at 
al., 1963). On the other hand, the use of alpha-methyI­
tyrosine (a-MT), an inhibitor of tyrosine hydroxylase, the 
enzyme that limits the formation of L-Dopa and eventually DA 
and NE, has produced a disruption of avoidance behavior in 
cats on a conditioned avoidance task in a shuttle box (Hanson, 
1965). Hanson also found that such disruptive effects of a-MT 
were completely reversed by the administration of 7.5 and 10 
mg/kg of L-Dopa given 15 hours after a-MT. 
These studies appear to be far from conclusive, how­
ever. Evidence suggests that behavioral deficits due to the 
administration of a-MT may be directly related to the rate of 
a-MT-produced brain-catecholamine depletion. While it was 
found that 200 mg/kg of peroral a-MT or multiple intraperi­
toneal injections of 150 mg/kg of a-MT did impair the per­
formance of rats in a shuttle box (Rech, Borys & Moore, 1966). 
it was suggested that the effects of higher dosages of a-MT 
(200-300 mg/kg) were due to the toxicity of a-MT. It is a 
distinct possibility that the disruption of the behavioral 
responses could be secondary to the toxic effects of a-MT on 
organ systems other than the eNS (Rech at al •• 1966; King, 
1971) • 
Examination of the effects of monoamine precursors 
and/or depletors on the acquisition of a behavioral response 
5 
often reveals sharp contrasts to studies of performance 
where the response has already been acquired prior to drug 
administration. For example, a-MT (100 mg/kg, ip) given 0-8 
hours before a I-trial passive avoidance task for mice re­
sulted in impaired avoidance acquisition (Essman, 1971). Yet, 
the depletion of brain NE by 6-hydroxydopamine (6-0HDA) in 
rats resulted in a significant increase in the rate of avoid­
ance acquisition (Cooper, Breese, Howard & Grant, 1972). In 
this study, Cooper at ale (1972) also reported that there was 
no difference in the number of avoidance responses made by 
rats that were depleted of DA, nor did rats reportedly de­
pleted of both DA and NE show any evidence of acquisition 
when compared to controls on a shuttle task. 
Administration of 5-HTP has been shown to facilitate 
the acquisition of a visual discrimination. It has been 
shown that increased brain levels of 5~HT can facilitate a 
visual discrimination as a consequence of the dosage level of 
5-HTP (Fifer2 & Whitehouse). In this study, the lowest dose of 
5-HTP (25 mg/kg, ip) resulted in a stimulus-dependent retarda­
tion effect when rats were trained to a simultaneous bright­
ness discrimination task. Earlier studies have shown that a 
drug-mediated elevation of brain 5-HT can result in a reduc­
o 
tion of learning efficiency in mice when the apparent source 
of motivation is the opportunity to hide from view in a T­
2Unpublished study entitled "Facili tation of Visual 
lliscrirnination Learning in the Rat by Increases in Brain 5­
Hydroxytryptophan ,u 1972. 
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maze (Woolley & Van Dar Hoeven, 196J). In this study acqui­
sition was impaired with 60 mg/kg of 5-HTP but the adminis­
tration of JOO mg/kg of 5-HTP further reduced learning ef­
ficiency. 
Essman (1971) reported a decrement in the acquisition 
of a l-trial passive avoidance response in mice that was de­
pendent upon the level of foot shock used. Weaker shock 
levels (J.O rnA) produced a 25 percent reduction and higher 
shock levels (6.0 rnA) a 10 percent reduction in acquisition. 
Recent attempts have been made to demonstrate the im­
portance of biogenic amines in the formation of long-term 
memory. It was reported that the lowering of brain NE content 
without concomitant DA depletion by the intraperitoneal adminis­
tration of a nonspecific depressor of brain monoamine levels, 
reserpine, immediately after training interfered with the 
acquisition of a shuttle response while the administration of 
L-Dopa (100 mg/kg, ip), 5-HTP (200 mg/kg, ip), and PCPA (J16 
mg/kg, ip) after training did not have any effect upon memory 
(Dismukes & Rake, 1972). In another study by Rake (197J) it 
was reported that reserpine (J.O mg/kg, ip) and L-Dopa (100 
mg/kg, ip) or reserpine (3.0 mg/kg, ip) and 5-HTP (200 mg/kg, 
ip) administered immediately after training of a step-through 
response enhanced acquisition. 
However, these designs fail to consider the time neces­
sary for the precursors or depletors of brain amines to cross 
the blood-brain-barrier. The intraperitoneal administration 
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of any drug for the purpose of enhancing or disrupting the 
memory trace is not congruent with the consolidation hypo­
thesis thereby suggesting that the consolidation of a memory 
trace takes place within a short period of time after the 
learning experience. Because of the possible peripheral ac­
tions of reserpine, L-Dopa or 5-HTP, one cannot be certain 
whether the central effects of these drugs or an alteration 
of afferent nervous activity were responsible for the effect 
upon acquisition. In fact, reserpine administered alone may 
cause a massive release of amines during the early stages of 
its action. 
The physiological effects of increased brain levels 
of 5-HT or DA have been described primarily in terms of their 
behavioral effects. But such studies often times fail to con­
sider the interaction effects of each of these amines upon the 
uptake, storage, and metabolism of the other neurohormone. The 
implications that 5-HT is an effective in vitro inhibitor of 
the enzymatic and auto-oxidation of DA and NE (Vander Wende & 
Johnson, 1970, Hartley & Smith, 1972) coupled with the fact 
that serotonergic nerve cell bodies and possibly serotonergic 
nerve terminals have the capacity to take up and concentrate 
catecholamin~s (Barrett & Balch, 1971) make it especially dif­
ficult to assess behavioral effects of precursor loading of 
5-HTP and L-Dopa. 
It has been suggested that a barrier for L-Dopa and 5­
H'l'P exists at the capillary level in the form of an enzymatic 
-~ 
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"trapping mechanism" (Hillarp, Fuxe & Dahlstrom, 1966). The 
possibility that dopa decarboxylase and monoamine oxidase are 
present in the walls of cerebral capillaries may be indicative 
of the degree of competition between the amine precursors for 
penetration into the brain. Such a barrier in combination 
with metabolic turnover as the mechanism for depletion of 
cerebral 5-HT following L-Dopa administration (Barrett & Balch, 
1971) could provide a possible explanation for the variety of 
results obtained by behavioral studies. 
It is interesting to note that McGeer, P. L., McGeer, 
E. G. & Wada (1963a) found that the administration of L-Dopa 
(30 mg/kg, ip) resulted in an increase of DA and NE as well as 
a decrease of brain 5-HT. The converse effect was obtained 
with 30 mg/kg of 5-HTP. There was a large increase in 5-HT 
accompanied by a decrease in catecholamines. This competition 
is further emphasized by data obtained by Wada et ale (1963). 
The administration of 5-HT to cats resulted in a deleterious 
effect on performance in a shuttle box but the administration 
of L-Dopa resulted in an improvement in performance. A most 
striking effect was obtained in studies where L-Dopa and 5-HTP 
were administered together. It was found that performance de­
pended not upon the absolute level of catecholamines or 5-HT 
present in the brain but rather on the balance between the 
catecholamines and 5-HT (Wada et al •• 196). 
No studies have been found in which the effects of in­
creased brain levels of 5-HT and DA are directly compared with 
9 
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respect to the acquisition of a particular behavioral task 
within the same study. This lack of comparative data makes 
it difficult to assess the significance of studies indicating 
that 5-HT and DA concentrations influence the uptake, storage 
and metabolism of each other. Studies by McGeer et ale (1963 
a) of the effects of brain amine levels on performance sup­
port biochemical and histological evidence of an interaction 
between 5-HT and DA. Other studies, previously mentioned, of 
the effects of 5-HTP and L-Dopa on performance and acquisition 
suggest the importance of these amine precursors in a learn­
ing situation. In view of the wida range of effects of 5-HT 
and DA precursors and/or depletors upon performance and learn­
ing, the purpose of the present study is to compare the ef­
fects of precursor loading of 5-HTP and L-Dopa on the acqui­
sition of a conditioned avoidance response. 
Secondary to a comparison of the effects of 5-HTP and 
L-Dopa on the acquisition of the same task, the present study 
attempted to demonstrate the ability of these amine precur­
sors to facilitate the acquisition of a visual discrimination. 
Since the effects of increased brain levels of 5-HT report­
edly result in behavioral deficits and/or performance de­
crements and L-Dopa produces a general increase in activity 
level. it would seem reasonable to expect that these effects, 
whether central, peripheral. or the result of a biochemical 
interaction. can serve to be operative upon the acquisition 
of a conditioned avoidance response. 
CHAPTER II 
METHOD 
Subjects 
Twenty-four male Swiss Webster albino mice, obtained 
from Blue Spruce Farms, Altamont, New York were used. The 
Ss, approximately 65 days old, were housed two to a cage for 
7 days prior to training. Each animal received food and 
water ad lib throughout the study. 
Apparatus 
The apparatus was a 45 x 16.25 x 17.50 em. shuttle box 
constructed of clear Plexiglas. The grid floor consisted of 
0.31 em. brass rods spaced 1.0 cm. apart on centers. Foot 
shock, supplied by a constant current source at 0.5-ma, was 
scrambled by a Davis Shock Scrambler (Davis Co., California). 
A barrier of black Plexiglas with a ).75 cm. dia. hole 
through its center was placed between the two chambers. The 
conditioned stimulus (CS) was two 12-v lamps (Chicago, CM­
1816) wired in parallel which comprised a single light source. 
The CS was located 10 em. above the grid floor between the 
two compartments. A 4.)8 em. opal glass lens was at a 450 
angle to each side of the apparatus. Latencies were re­
corded by a Standard Electric clock that was activated at 
the onset of each trial and terminated when the respective 
photorelay was tripped as the animal entered the safe cham­
ber. During the inter-trial interval. foot shock was always 
available to one side of the apparatus in order to discourage 
11 
inter-trial crossovers. Ambient light was supplied by a 7-w 
red bulb. The shuttle box was placed in a sound attenuated 
room and, except for the shock scrambler, all electronic 
equipment and relays were located in an adjacent room. 
Procedure 
Each animal was randomly assigned to one of three 
groups. Group 1 and group 2 received 50 mg/kg of 5-hydroxy­
DL-tryptophan (5-HTP) and 100 mg/kg of 3,4-dihydroxypheny­
lalanine (L-Dopa), respectively. 5-HTP and L-Dopa were 
dissolved in 0.10 N hydrochloric acid and the pH was adjusted 
to approximately 7.40 with 10 N sodium hydroxide in 0.10 N 
hydrochloric acid. Group 3. the vehicle control. was admin­
istered the vehicle used to prepare the drugs for injection. 
All injections were given intraperitonealy and ware of equal 
volume. e.g•• 0.50 cc per injection. Solutions containing 
the drugs were prepared on a daily basis. 
All S8 received drug injections daily one hour prior 
to training. Each Sreceived a total of twenty trials daily. 
The ~s were run by groups with the sequence of the groups 
varying randomly each day. The onset of the CS signaled the 
start of each trial. Foot shock was delivered la-sec. after 
the onset of the CS and remained on until the §. crossed over 
to the other side of th.e apparatus. If §.. responded with a 
latency of less than la-sec., the response was defined as an 
avoi.dance. If the la'tency exceeded 10-sec., the response was 
defined as an escap~. The 58 were placed alternately in 
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either the right or left side of the apparatus at the be­
ginning of each block of trials. The inter-trial interval 
varied randomly from la-sec. to 3D-sec. with a mean of 20­
sec. The CS terminated with each successful avoidance or 
escape. Training was terminated when all three groups had 
attained a level of 80 percent correct responding on the 
thirteenth day of training. 
'i 
CHAPTER III 
RESULTS 
At no time did any of the animals show signs of ataxia 
or diarrhea following the injections of 5-HTP, L-Dopa or the 
vehicle. Nor were there any differences in the mean body 
weight between the groups. It did, however, become obvious 
after the third day of training that the L-Dopa group was 
more sensitive to handling than the other two groups. This 
hypersensitivity persisted throughout the remainder of the 
study. 
Mean latencies for all groups are shown in Figure 1. 
A two-way analysis of variance with repeated measures per­
formed on the latency of the response for 13 days of training 
resulted in a nonsignificant drug effect (X = 1.48. ~ =2/21, 
P > .05). Analysis of the latency of response for the first 6 
days of training revealed a significant drug effect (F = 4.44. 
df = 2/21. P < .05). Subsequent analysis of the drug effect 
by the Tukey test showed no difference for L-Dopa VB Control 
(~ = 1.37. £! = 1/42. f > .05), 5-HTP VB Control ,~ = 0.47. 
df = 1/42. P > .05), ~~d L-Dopa VB 5-HTP (~ = 0.87. df = 1/42, 
P > .05). The test for homogeniety of variance assumption is 
valid for latencies (C = 0.4828). Computation of the omega 
coefficient for latencies for the first 6 days accounts for 
226 percent of the variance for the drug effect (w = 0.26). 
A two-way analysis of variance with repeated measures 
performed on the percent of avoidance resulted i.n a nonsig­
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Figure 1. The effect of 5-HTP and L-Dopa on response latency. Each 
value represents the mean ± S.E.M. for each group. There is no dif~~ 
~ence between any of the groups (p > .05). 
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nificant drug effect for 13 days of training (F = 0.74, ~ =
 
2/21. 1: > .05) and the first 6 days of training (1: = 0.75,
 
df = 2/21, f > .05). As can be seen in Figure 2, daily train­

ing sessions for 13 days were highly effective (l = 129.37,
 
2!: == 12/252, P < .001). There was a drug x trials inter­

action for 13 days of trainingC'l ::: 1.60, df = 24/252, P <
 
.05) and the first 6 days of training (l = 5.94, df = 10/105,
 
E < .001). The test for homogeniety of variance assumption
 
is valid for the avoidance measure (C ::: 0.3828) and the drug
 
by trials interaction accounts for 65 percent of the variance
 
for the first 6 days of training (w2 ::: 0.65). I.'tl.
~L 
ill! 
A two-way analysis of variance with repeated measures 
performed on the frequency of inter-trial crossovers indic­
ates a significant drug effect for 13 days (F ::: 17.72, df = 
2/21, f < .001). As can be seen in Figure 3. the L-Dopa 
group had significantly more crossovers than the 5-HTP group 
(~ ::: 14.59. ££ ::: 2/21, P < .01) and the Control group (~ ::: 
17.15. df := 2/21, P < .01). There was no difference between 
the 5-HTP and Control groups (.9. 2.56, df 2/21, 1: > .0.5).:t l: 
The test for homogeniety of variance assumption is valid for 
crossovers (C = 0.5912) and computation of the omega co­
effi.cient indicates that the drug effect accounts for 60 
2percent of the variance (w = 0.60). 
The Duncan New Multiple Range Test performed on the 
first 2 days of training indicates that the 5-HTP group pro­
duced significantly more crossovers than the Control group 
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on day 1 (p < .005) and day 2 (~< .05). There was no diff­
erence between the L-Dopa and 5-HTP groups for either day 1 
or day 2 (p > .05). 
CHAPTER IV 
DISCUSSION 
The results of the present study indicate that the 
administration of 5-HTP (50 mg/kg) or L-Dopa (100 mg/kg) 
does not facilitate the acquisition of a conditioned avoid­
ance response. Analysis of the percent of avoidances for the 
first six days revealed a sUbject by treatment interaction. 
After the third day of training the L-Dopa group was more 
sensitive to handling than any other group. The 5-HTP group 
showed a significant decrease in the number of inter-trial 
crossovers during the first two days of training. 
The finding that 5-HTP did not facilitate acquisition 
as measured by latency and percent of avoidances does not 
agree with studies suggesting that the administration of 5-HTP 
enhances learningl nor does it coincide with studies demon­
strating a decrement in learning or performance. Though the 
present study does not permit an analysis of peripheral drug 
effects, the results do not appear to be influenced by the 
effects of precursor loading of 5-HTP on activity level and 
mobility. Studies of the effects of small doses of 5-HTP 
(6.25-50 mg/kg. ip) administered to male albino mice have 
shown that spontaneous activity was not affected (Modigh, 
1972. 1973). 
Increased brain levels of DA have been reported to 
result in an increase of spontaneous motor activity (Eiduson 
at al. t 19641 Kellogg & Lundborg, 1972, Geyer, Segal & 
· 20 
Mandell, 1972) and agressiveness (Lycke, Modigh & Roos, 
1969). It seems likely that a change in motor activity due 
to the conversion of L-Dopa to DA and NE (Geyer at al •• 1972) 
influenced the acquisition of avoidance responding. The 
effects of L-Dopa on activity level would appear to be re­
sponsible for the significant number of inter-trial cross­
overs produced. In the sense that inter-trial crossovers are 
an indication of activity level, the results of the present 
study due to the administration of L-Dopa coincide well with 
studies which report an enhancement of performance on a con­
ditioned avoidance task. 
In conjunction with a heightened actiVity level as 
displayed by the L-Dopa group. the effects of aversive stimuli 
may have served to impair the learning of an active avoidance 
task. The fact that inter-trial crossovers were discouraged 
appears to have complicated the learning task; this is true 
since repeated errors during the inter-trial interval were 
immediately followed by foot shock. A higher incidence of 
foot shock for those animals that had a greater tendency to 
crossover between trials might have conflicted with acquisi­
tion. Because foot shock followed the correct motor response 
when an animal produced an inter-trial interval crossover, it 
is possible that the overall number of avoidances were decreased. 
Within the parameters of the present study the effects 
of 5-HTP on inter~trial crossovers are difficult to explain. 
The significant decrease in inter-trial crossovers during the 
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first two days of training might reflect a possible release 
of catecholamines as a result of the initial administration 
of 5-HTP. In view of the fact that 5-HTP results in a higher 
threshold for foot shock (Tenen. 1967). it is not surprising 
that the 5-HTP group did not differ from Controls. Relatively 
high foot shock levels have been reported to have little effect 
upon acquisition (Essman. 1971). 
A possible explanation of the effect of 5-HTP can be 
found in a study of the effects of microelectrophoretically 
administered 5-HT on the neurons of the lateral geniculate 
body in unanaesthetized (decerebrate) cats. The depressant 
action of 5-HT on the lateral geniculate neurons was found to 
be dose dependent. Low injecting currents easily depressed 
the orthodromic firing by light stimUlation and nerve stim­
ulation via acetylcholine. Higher injecting currents had a 
greater effect on the depression of both antidromic and ortho­
dromic firing and spontaneous activity than did DA and NE 
(Tebecis & Di Maria. 1972). Such results provide evidence 
that tryptamine derivatives may have a role in blocking the 
release of the excitatory transmitter from optic nerve ter­
minals. or preventing its availability to lateral geniculate 
neurons. Histochemical evidence suggests that the pathway 
for tryptaminergic afferent fibers to the lateral geniculate 
neurons originates in the brain stem. In view of the fact 
that the stimulation of the mesencephalic reticular formation 
depresses activity of the lateral geniculate neurons (Tebecis 
& Di. Mariat 1972). it would seem reasonable to suggest that 
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increased regional concentrations of 5-HT can serve to in­
hibit the acquisition of a visual task. Nevertheless, it 
would appear tha,t a more sensitive test than the present 
methodology permits is necessary in order to assess the 
effects of 5-HTP on acquisition, 
The assumptions of a nonadditive model for the analysis 
of variance suggest a subject x treatment interaction (Hays, 
1963; Edwards, 1968s Myers, 1966). Implications of such 
interactive effects indicate that the daily administration 
of 5-HTP and L-Dopa did not produce effects that were constant 
across the training sessions. The possibility exists that 
the effects of metabolites of L-Dopa and 5-HTP varied within 
subjects as a funct.ion of the daily drug administration. 
It has been demonstrated that brain levels of DA and 
5-HT co-vary as a function of the particular precursor admin­
istered as well as the quantity administered (Everett & Borch­
erding, 1970, Okada et al •• 1972. McGeer et al., 196)a) and 
that brain concentrations of 5-HT and NE are increased as a 
result of forced mobility (Elo & Tirri, 1972) and foot shock 
(Bliss, Ailion & Zwanziger. 19681 Thierry, Javoy, Glowinski 
& Kety, 1968). The effect of 5-HTP on the catecholamines and 
of L-Dopa on 5-HT, in addition to the alteration of 5-HT and 
NE concentrations by active avoidance or escape of foot shock, 
appear to have confounded the present results. 
Though the first six days of training resulted in a 
significant drug effect, it was not possible to determine the 
2)
 
particular drug affecting acquisition. For this reason 
future studies of the effects of amine precursors might 
include a study of the interactive effects of these amines 
by the administration of both .5-HTP and L-Dopa in varying 
quantities. Utilizing such a methodology it might be poss­
ible to determine which drug has the greater effect upon 
acquisition, if any. However, since the decarboxylase act­
ivity of 5-HTP and L-Dopa are in constant ratio to each 
other in brain tissue (Friede, 1966) and the decarboxy­
lation of these amines is mediated by the same enzYme (Cooper, 
Bloom & Roth, 1970, Carlsson, 1964), it is difficult to 
attempt an analysis of behavioral effects without first 
establishing correlations between variations in regional con­
centrations and specific behavior. The establishment of 
variations in regional concentrations of .5-HT and DA is most 
important when one attempts to examine central and/or peri­
pheral effects of such amines upon specific behavior. 
e 
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TABLE 1 
Analysis of variancel latency data for 13 days 
of training. 
Source df SS EMS F 
Between 
Drug 
Error 
2 
21 
16.60 
117.65 
8.)0 
5.60 
1.48 
Within 
Trials 12 994.93 82.91 
... *...30.94 
Trials 
drug 
Error 
x 
24 
252 
)8.06 
674-.95 
1.59 
2.68 
0.59 
***~ < .001
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TABLE 2 
Analysis of variancec latency data for the first 
6 days of training. 
Source df SS EMS F 
Between 
Drug 2 25.29 12.65 4.44* 
Error 21 59.81 2.85 
'iJi thin 
Trials .5 229.76 45.95 48.37
...* 
Trials 
drug 
Error 
x 
10 
105 
15.40 
99.79 
1.,4 
0.95 
1.62 
*p < .Os 
***f. < .001 
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TABLE J 
Analysis of variance, frequency of avoidance for 
13 days of training. 
Source df ss EMS F
 
Between 
Drug 
Error 
2 
21 
91.41 
1,305.36 
45.71 
62.16 
0.7'4­
within 
Trials 12 8,724.53 727.04 ***'129.37 
Trials 
drug 
Error 
x 
24 
252 
215.92 
1,415.40 
8.99 
5.62 
...1.60 
*p < .05 
***f. < .001 
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TABLE 4 
Analysis of variances frequency of avoidance for 
the first 6 days of training 
Source df S3 EMS F 
Between 
Drug 
Error 
2 
21 
60.43 
847.88 
30.22 
40.38 
0.15 
Within 
Trials 
Trials 
drug 
Error 
x 
5 
10 
105 
8)6.89 
191.07 
338.)7 
167.)8 
19.11 
J.22 
***56.)6 
4**"5.9 
***.'f < .001
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TABLE 5 
Analysis of variancea frequency of inter-trial 
crossovers for 13 days of training. 
Source df SS EMS F 
Between 
Drug 2 42.35 21.18 .........17.72 
Error 21 25.10 1.20 
Within 
Trials 12 16.26 1.)6 **2.26 
Trials x 
drug 24 20 • .57 0.86 1.43 
Error 252 150.02 0.60 
**p < .01 
***p < .001 
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TABLE 6 
Duncan New Multiple Range Testr comparison of the mean 
number of inter-trial crossovers for each group for the 
first day of training. 
Means 
Control 
.125 
L-Dopa 
1.38 
5-HTP 
1.?5 
Shortest 
Significant 
Ranges 
Control = .1) it*1.26 **1.6; R-2 1.2488= 
L-Dopa :: 1.38 .J? R-J = 1.2994 
**p < .005 
s J
 
)8
 
TABLE 7 
Duncan New Multiple Range Testa comparison of the mean 
number of inter-trial crossovers for each group for the 
second day of training. 
Means 
Control 
.38 
L-Dopa 
1.25 
5-HTP 
1.25 
Shortest 
Significant
Ranges 
Control = .38 *.87 *.87 .6490R..2 = 
L-Dopa = 1.25 0.00 R-3 = .6813 
*p < .05 
APPENDIX B
 
TEST DATA
 
MEAN DAILY LATENCIES
 
-

TABLE 8 
Mean daily latencies for each subject 
L-Dopa Group 
Days 
1 2 3 4 5 6 7 8 
1 13.14 11.69 12.95 12.46 11.23 11.23 11.13 12.79 
2 10.61 10.81 10.48 9.16 12.51 10.22 10.)2 10.53 
3 10.83 10.1) 9.65 8.22 10.61 8.1) 7.90 10 .. 29 
4 8.76 9.)8 7 .. 86 6.38 7.94 8.38 7.14 9.97 
5 8 .. 09 8.42 8.86 6.)1 9.74 9.35 3.27 8 • .56 
6 8.)9 8.69 8.70 8.68 7.28 8.80 5.23 8.53 
7 7.46 7 .. 80 9.72 6.45 7.0) 7.92 5.32 8.66 
8 6.95 8.05 6.41 5.27 5.36 7.28 5.42 8.15 
9 6.67 5.92 8.22 5.19 6.02 6•.38 5.70 B.22 
10 8.91 7.78 7.05 6.27 6.73 6.89 5.84 6.59 
11 8.6) 6.39 5.25 4.39 4.84 6.21 5.09 7.17 
12 6.47 6.)3 6.26 5.78 5.79 5.84 \ 5.42 7.97 
1) 6.20 5.45 5.)7 6.16 5.90 5.94 6.08 7.22 
TABLE 9
 
Mean daily latencies for each subject
 
5-HTP Group
 
Days 
1 2 3 4 5 6 7 8 
1 11.)1 10.34 10.60 10.55 11.53 10.88 11.1.5 10.44 
2 10e'? 10.70 11.86 11.48 10.91 9.85 10.95 9.28 
3 10.76 11.32 9.13 10.00 11.85 8.80 10.52 8.81 
4 10 .. 16 10.37 9.03 10.84 10.46 10.73 9.92 7.36 
5 8.'74 8.31 8.56 10.05 9.43 9.59 9.94 7.66 
6 9.24­ 8.48 7.33 8070 9.78 8.79 10.57 6.96 
7 9.20 8.84 7.85 . 8.22 8.95 7.68 8.92 4.81 
8 7.74 6.38 8.57 8.03 5.60 5.74 6.36 5.39 
9 7.10 7.78 7.71 8.11 7.29 6.77 7.40 5.90 
10 7.43 7.17 7.56 7.60 6.90 8.05 7.69 5.53 
11 6.23 6.62 7.57 6.77 7.33 6.06 7.03 6.35 
12 6.93 6.43 7.17 6.83 6.50 5.43 6.18 6.2) 
13 7.76 7.09 5.28 5.90 5.88 6.69 7.45 6.54 
TABLE 10
 
Mean daily latencies for each subject
 
Control Group
 
Days 
1 2 3 4 5 6 7 8 
1 13.00 12.81 12.42 12.98 12.28 12.49 13.64 11.69 
2 12 0 94 10.87 11.71 10.38 10.96 11.21 11.49 11.16 
:3 11.75 10.25 10.59 10.11 10.37 10.45 10.64 10.36 
4 9.30 8.88 10 .. 20 8.37 11.24 10.73 9.83 7.09 
5 9.04 8.97 8.09 6.39 9.30 9.24 9.29 7.47 
6 9.82 9 .. 35 6.79 7.03 9.22 8.94 9.63 8.12 
7 9.03 7.84 5.49 7.24 7.82 6.71 6.74 6.16 
8 9.18 7.71 6.08 4.63 6.44 7.66 7.60 6.93 
9 8.42 9.14 7.98 7.37 5.85 7.63 7.91 6.02 
10 8.22 6.15 6.40 4.49 6.83 6.43 7.37 6.38 
11 7.92 6.41 6.69 5.63 5.84 5.92 4.73 6.64 
12 7.51 6.62 7.05 6.71 5.31 5.96 6.31 6.98 
1) 6.26 6•.37 6.43 7.08 6.57 6.29 7.42 6.09 
